IP Library Granted Patent US 8,178,666
Granted Patent B2
US 8,178,666 · App. 12/604,491 · Granted May 15, 2012

2-aminobenzoxazole process

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,178,666
App. No.
12/604,491
Granted
May 15, 2012
Kind
B2
Abstract

A method for forming an optionally substituted 2-aminobenzoxazole compound includes: contacting an optionally substituted 2-aminophenol compound with (1) an amine of the formula NHR 2 R 3 , wherein R 2 and R 3 are each independently selected from H, an optionally substituted alkyl group or an optionally substituted aryl group, or R 2 and R 3 , taken together with the nitrogen atom to which they are attached, form an optionally substituted heterocyclic ring; and (2) a reactant selected from the group consisting of: (a) C(OR) 4 , wherein R represents an alkyl group; (b) C(OAr) 4 , wherein Ar represents an aryl group; and (c) CCl 2 (OAr) 2 , wherein Ar represents an aryl group, in combination with a base; thereby forming the optionally substituted 2-aminobenzoxazole compound.

Claims (26)

1. A method for forming an optionally substituted 2-aminobenzoxazole compound, said method comprising:

contacting an optionally substituted 2-aminophenol compound with

(1) an amine of the formula NHR 2 R 3 , wherein R 2 and R 3 are each independently selected from H, an optionally substituted alkyl group or an optionally substituted aryl group, or R 2 and R 3 , taken together with the nitrogen atom to which they are attached, form an optionally substituted heterocyclic ring; and

(2) a reactant selected from the group consisting of:

(a) C(OR) 4 , wherein R represents an alkyl group;

(b) C(OAr) 4 , wherein Ar represents an aryl group; and

(c) CCl 2 (OAr) 2 , wherein Ar represents an aryl group, in combination with a base;

thereby forming said optionally substituted 2-aminobenzoxazole compound.

2. The method of claim 1 wherein said contacting is carried out in the presence of a solvent.

3. The method of claim 2 wherein said solvent is selected from the group consisting of methanol, ethanol, isopropyl alcohol, acetonitrile, tetrahydrofuran, ethyl acetate, toluene, chloroform, and combinations thereof.

4. The method of claim 3 wherein said solvent further includes an acid.

5. The method of claim 1 wherein R represents a methyl group or an ethyl group.

6. The method of claim 1 wherein Ar represents a phenyl group.

7. The method of claim 1 wherein said contacting is carried out at a temperature of about normal room temperature to about 80° C.

8. The method of claim 1 wherein said base comprises a tertiary amine or an aromatic nitrogen heterocycle.

9. The method of claim 8 wherein said base comprises triethylamine.

10. The method of claim 1 wherein at least one of R 2 and R 3 comprises an alkyl group.

11. The method of claim 1 wherein R 2 and R 3 together comprise an alkylene group.

12. The method of claim 1 wherein said amine comprises a primary amine.

13. The method of claim 1 wherein said amine comprises a cycloalkyl secondary amine.

14. The method of claim 1 wherein said amine comprises a heterocyclic secondary amine.

15. The method of claim 14 wherein said heterocyclic secondary amine is N-Boc-piperazine.

16. The method of claim 1 wherein said optionally substituted aryl group in said amine comprises substituents selected from alkyl, aryl, heteroaryl, halo, alkoxy, hydroxyl, acyl, carboalkoxy, carboxy, nitro, and combinations thereof.

17. The method of claim 1 wherein said amine of the formula NHR 2 R 3 is selected from the group consisting of:

18. The method of claim 1 wherein said optionally substituted 2-aminophenol compound is selected from the group consisting of:

19. The method of claim 1 wherein said optionally substituted 2-aminobenzoxazole compound is selected from the group consisting of:

Assignments (12)
CHANGE OF NAME Recorded May 20, 2025
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 071298/0097 →
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON SEPTEMBER 1, 2017, AT REEL/FRAME 043746/0621 Recorded Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
SECURITY INTEREST Recorded Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC); CURIA NEW MEXICO, LLC (FKA OSO BIOPHARMACEUTICALS MANUFACTURING, LLC); CURIA IP HOLDINGS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
Reel/Frame 054252/0687 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 7541537 PREVIOUSLY RECORDED AT REEL: 034045 FRAME: 0951. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
FIRST LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC-BY ITS SOLE MEMBER: ALO ACQUISITION LLC
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING LLC-BY ITS SOLE MEMBER:ALO ACQUISITION LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2010
From: CIOFFI, CHRISTOPHER
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023808/0071 →